Atlas Trials

Study of Ombitasvir/Paritaprevir/Ritonavir in Japanese Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection With End Stage Renal Disease (ESRD) on Hemodialysis (HD)

Clinical trial NCT02806362 · WITHDRAWN

Trial details

NCT number
NCT02806362
Sponsor
AbbVie
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Chronic Hepatitis C Virus
Start date
2016-09-01
Primary completion
2018-06-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.